Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Topf, H.-G.
Schwarze, B.
Köhler, H.
Neubert, A.
and
Rascher, W.
2013.
Schwerwiegende Nebenwirkungen durch nasales Xylometazolin.
Monatsschrift Kinderheilkunde,
Vol. 161,
Issue. 6,
p.
537.
Salmane-Kulikovska, Ieva
and
Mezinska, Signe
2013.
‘I had to help my child!’:.
Journal of Child Health Care,
Vol. 17,
Issue. 1,
p.
41.
Figueiras-Graillet, Lourdes M.
Martínez-Sellés, Manuel
Perez-David, Esther
and
Fernandez-Avilés, Francisco
2013.
Reversible cardiomyopathy due to chronic use of xylometazoline topical nasal spray.
International Journal of Cardiology,
Vol. 164,
Issue. 2,
p.
e17.
Latham, Gregory J.
Jardine, David S.
and
Polaner, David
2013.
Oxymetazoline and hypertensive crisis in a child: can we prevent it?.
Pediatric Anesthesia,
Vol. 23,
Issue. 10,
p.
952.
Tobias, Joseph D.
Cartabuke, Richard
Taghon, Thomas
and
Morton, Neil
2014.
Oxymetazoline (Afrin®): maybe there is more that we need to know.
Pediatric Anesthesia,
Vol. 24,
Issue. 8,
p.
795.
Hakim, Mumin
Walia, Hina
Rafiq, Mahmood
Grannell, Timothy
Cartabuke, Richard S.
and
Tobias, Joseph D.
2016.
Oxymetazoline Metered Dose Spray: Factors Affecting Delivery Volume.
The Journal of Pediatric Pharmacology and Therapeutics,
Vol. 21,
Issue. 3,
p.
247.
Cartabuke, Richard S.
Anderson, Brian J.
Elmaraghy, Charles
Rice, Julie
Tumin, Dmitry
and
Tobias, Joseph D.
2019.
Hemodynamic and pharmacokinetic analysis of oxymetazoline use during nasal surgery in children.
The Laryngoscope,
Vol. 129,
Issue. 12,
p.
2775.
van Hunsel, Florence
and
van Puijenbroek, Eugène
2020.
Hartritmestoornissen door xylometazoline bij patiënten met een lang-QT-syndroom.
Huisarts en wetenschap,
Vol. 63,
Issue. 8,
p.
56.
Tunkel, David E.
Anne, Samantha
Payne, Spencer C.
Ishman, Stacey L.
Rosenfeld, Richard M.
Abramson, Peter J.
Alikhaani, Jacqueline D.
Benoit, Margo McKenna
Bercovitz, Rachel S.
Brown, Michael D.
Chernobilsky, Boris
Feldstein, David A.
Hackell, Jesse M.
Holbrook, Eric H.
Holdsworth, Sarah M.
Lin, Kenneth W.
Lind, Meredith Merz
Poetker, David M.
Riley, Charles A.
Schneider, John S.
Seidman, Michael D.
Vadlamudi, Venu
Valdez, Tulio A.
Nnacheta, Lorraine C.
and
Monjur, Taskin M.
2020.
Clinical Practice Guideline: Nosebleed (Epistaxis).
Otolaryngology–Head and Neck Surgery,
Vol. 162,
Issue. S1,
Cartabuke, Richard
Tobias, Joseph D.
and
Jatana, Kris R.
2021.
Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use.
Pediatrics,
Vol. 148,
Issue. 5,
Jones, Robert S.
2021.
Conceptual Model for Using Imidazoline Derivative Solutions in Pulpal Management.
Journal of Clinical Medicine,
Vol. 10,
Issue. 6,
p.
1212.
Stjepanovic, Ana N.
Todorovic, Nemanja B.
Tesic, Tamara Z.
Komazec, Zoran S.
Canji-Panic, Jelena M.
and
Lalic-Popovic, Mladena N.
2022.
Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines.
Regulatory Toxicology and Pharmacology,
Vol. 133,
Issue. ,
p.
105225.
Brattström, Petter
Moresco, Luca
Nussbaumer-Streit, Barbara
Bruschettini, Matteo
and
Gisselsson-Solen, Marie
2023.
Decongestants and antihistamines for acute otitis media in children.
Cochrane Database of Systematic Reviews,
Vol. 2023,
Issue. 11,
Masoudifar, Mehrdad
Rezaeian, Ahmad
and
Mosharaf, Sheida
2023.
The Effect of Half Percent Oxymetazoline Nasal Drops on Post-Tonsillectomy Cough, Sore Throat and Bleeding in Children; a Double-Blind Randomized Clinical Trial.
Advanced Biomedical Research,
Vol. 12,
Issue. 1,
Petkovic, Stasa
Maletic, Ivana
Djuric, Sonja
Dragutinovic, Ninoslava
and
Milovanovic, Olivera
2024.
Evaluation of Nasal Decongestants by Literature Review.
Experimental and Applied Biomedical Research (EABR),
Vol. 25,
Issue. 2,
p.
181.